Suchergebnisse - "Guzelj, Samo"

PubPharm (16)

1

Discovery of 2,3-Diaminoindole Derivatives as a Novel Class of NOD Antagonists

enthalten in: Journal of medicinal chemistry | 2024

von Russo, C. | Russomanno, P. | D'Amore, V. | +13

2

CONJUGATED TLR7 AND NOD2 AGONISTS

enthalten in: Europäisches Patentamt | 2023

von JAKOPIN ZIGA | GUZELJ SAMO

3

CONJUGATED TLR7 AND NOD2 AGONISTS

enthalten in: Europäisches Patentamt | 2023

von JAKOPIN ZIGA | GUZELJ SAMO

4

CONJUGATED TLR7 AND NOD2 AGONISTS

enthalten in: Europäisches Patentamt | 2023

von JAKOPIN ŽIGA | GUZELJ SAMO

5

CONJUGATED TLR7 AND NOD2 AGONISTS

enthalten in: Europäisches Patentamt | 2023

von JAKOPIN ŽIGA | GUZELJ SAMO

6

Lipidation of NOD2 Agonists with Adamantane and Stearoyl Moieties Differentially Regulates Their In Vivo Adjuvant Activity

enthalten in: Pharmaceutics | 2022

von Guzelj, S. | Šišić, M. | Bizjak, �. | +3

7

Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators

enthalten in: Journal of medicinal chemistry | 2022

von Guzelj, S. | Weiss, M. | Slütter, B. | +2

8

Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency

enthalten in: ACS medicinal chemistry letters | 2022

von Guzelj, S. | Bizjak, �. | Jakopin, �.

9

Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual Screening

enthalten in: Biomolecules | 2022

von Guzelj, S. | Tomašič, T. | Jakopin, �.

10

CONJUGATED TLR7 AND NOD2 AGONISTS

enthalten in: Europäisches Patentamt | 2022

von JAKOPIN ŽIGA | GUZELJ SAMO